Short answer
Outset Medical, Inc. (OM) filed its Q3 2025 10-Q quarterly report on Nov 10, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $29M (up 2.7% year over year) with net income of −$18M.
Q3 2025 key financials · XBRL
- Revenue
- $29M
- +2.7% YoY · −6.3% QoQ
- Net income
- −$18M
- +36.2% YoY · +3.8% QoQ
- Operating margin
- -53.7%
- Gross margin
- 39.4%
- EPS (diluted)
- −$0.80
- −50.9% YoY · −988.9% QoQ
Source: XBRL data from the Outset Medical, Inc. (OM) Q3 2025 10-Q on SEC EDGAR. USD.
Outset Medical, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New manufacturing risk from insourcing production in Mexico, partly triggered by ramping cartridge manufacturing and dependence on Mexico facility
- Updated trade tariff risk due to Feb-Mar 2025 executive orders imposing 25% tariffs on Mexico and 20% on China imports, with ongoing Section 232 investigation
- Compliance risk from potential changes in Mexico labor laws aiming 40-hour workweek by 2030, possibly increasing labor costs and impacting productivity
- Operational risk from manufacturing disruptions at Mexico facility or Southeast Asia contract partner due to labor disputes, health crises, or geopolitical issues
- Cybersecurity risk heightened by reliance on cloud providers like AWS and increased remote work, exposing potential data breaches affecting patient data and business continuity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Outset Medical, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.